Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Ltd ADR
(NY:
TAK
)
14.76
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ltd ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Pressure Day
September 13, 2021
Today a recovery came to markets with a particular impact on uranium shares.
Via
Talk Markets
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Novavax Stock Is Slipping Again Today
September 10, 2021
A reported delay in India's EUA for Novavax's COVID-19 vaccine appears to still be weighing on the stock.
Via
The Motley Fool
Exposures
COVID-19
Why Novavax Stock Surged Today
September 07, 2021
The biotech's coronavirus-related revenue could be about to soar.
Via
The Motley Fool
Exposures
COVID-19
Analyzing Takeda Pharmaceutical's Unusual Options Activity
August 03, 2021
Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ...
Via
Benzinga
Understanding Takeda Pharmaceutical's Unusual Options Activity
July 30, 2021
Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ...
Via
Benzinga
NVAX Stock: The Big Reason Why Novavax Shares Are Gaining Today
September 07, 2021
A Japanese pharma giant has partnered with Novavax to supply millions of vaccines. NVAX stock is reacting accordingly.
Via
InvestorPlace
Exposures
COVID-19
Novavax Shares Surge On Vaccine Supply Deal With Japan
September 07, 2021
Novavax, Inc. shares were trading higher Tuesday following the signing of a coronavirus vaccine supply deal.
Via
Talk Markets
Exposures
COVID-19
Novavax Shares Surge On Vaccine Supply Deal With Japan
September 07, 2021
Novavax, Inc. (NASDAQ: NVAX) shares were trading higher Tuesday following the signing of a coronavirus vaccine supply deal. What Happened: Japanese pharma giant Takeda...
Via
Benzinga
Exposures
COVID-19
Mu - The Newest Worry
September 03, 2021
Today London and New York fell on the huge drop in new employment levels in August.
Via
Talk Markets
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The trial did...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
September 01, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
September 01, 2021
Moderna, Inc. (NASDAQ: MRNA) found itself in a controversy after Japan suspended the use of about 2.6 million doses of the company's COVID-19 vaccine following reports of...
Via
Benzinga
Exposures
COVID-19
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ)...
Via
Benzinga
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
August 30, 2021
After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19...
Via
Benzinga
Topics
Death
Exposures
COVID-19
Death
Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters
August 27, 2021
Metallic particle is believed to be a contaminant found in a batch of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines delivered to Japan, Japanese public broadcaster...
Via
Benzinga
Exposures
COVID-19
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received...
Via
Benzinga
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
August 26, 2021
More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia...
Via
Benzinga
Exposures
COVID-19
BioLife Plasma Services Opens First All-Electric Plasma Donation Center
August 18, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
Takeda To Lead Finch-Partnered Microbiome IBD Drug
August 10, 2021
Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN...
Via
Benzinga
Why BioCryst Pharmaceuticals Rose 8% on Thursday
August 05, 2021
The company's first commercial drug launch keeps exceeding expectations.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Product Safety
Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
August 05, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Know When To Hold 'Em, Know When To Fold 'Em ...
August 02, 2021
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.
Via
Talk Markets
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
August 01, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
July 30, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
July 29, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
July 28, 2021
The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.